Safety and short-term efficacy of adjuvant nivolumab after neoadjuvant docetaxel, cisplatin, and fluorouracil for locally advanced esophageal squamous cell carcinoma.

被引：0
|
作者：
Okunaka, Mashiro
Kotani, Daisuke
Sato, Kazuma
Fujiwara, Naoto
Mishima, Saori
Shitara, Kohei
Fujita, Takeo
Kojima, Takashi
机构：
[1] Natl Canc Ctr Hosp East, Dept Pharm, Kashiwa, Japan
[2] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Japan
[3] Natl Canc Ctr Hosp East, Div Esophageal Surg, Kashiwa, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
261-3278; 613-4678-146; 281-318-430; 261-492-2769; 283-424-6846-271-2644; 613-135-244-3829-325; 613-135-2370-7650-2454; 7; 5; 4; 3; 14; 154; 54; 256; 3592; 8; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.271
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：271 / 271
页数：1
相关论文
共 50 条
  • [41] Safety of Neoadjuvant Chemoradiotherapy Followed by Surgery for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
    Herbella, Fernando A. M.
    Patti, Marco G.
    JAMA SURGERY, 2021, 156 (05) : 452 - 452
  • [42] Safety and efficacy of conversion therapy for esophageal squamous cell carcinoma.
    Tsuji, Takayuki
    Kawakubo, Hirofumi
    Takeuchi, Masashi
    Matsuda, Satoru
    Fukuda, Kazumasa
    Nakamura, Rieko
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 362 - 362
  • [43] Safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (Neo DCF) therapy for locally advanced esophageal cancer: Real world data analysis.
    Tamba, Mikako
    Osumi, Hiroki
    Fukuoka, Shota
    Ogura, Mariko
    Okamura, Akihiko
    Kanamori, Jun
    Imamura, Yu
    Takahari, Daisuke
    Yoshino, Koichiro
    Udagawa, Shohei
    Wakatsuki, Takeru
    Shinozaki, Eiji
    Watanabe, Masayuki
    Yamaguchi, Kensei
    Chin, Keisho
    Ooki, Akira
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 365 - 365
  • [44] NEOADJUVANT CHEMOTHERAPY WITH ETOPOSIDE, LEUCOVORIN, 5-FLUOROURACIL AND CISPLATIN FOR ADVANCED ESOPHAGEAL SQUAMOUS-CELL CARCINOMA
    OHWADA, S
    NAKAMURA, S
    IZUMI, M
    KAWASHIMA, Y
    OGAWA, T
    KOBAYASHI, I
    HOSOMURA, Y
    JOSHITA, T
    LINO, Y
    MORISHITA, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1995, 25 (03) : 79 - 85
  • [45] Neoadjuvant camrelizumab plus docetaxel and carboplatin in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective study
    Wang, R.
    Zhang, G.
    Zhu, Q.
    Ma, T.
    Weng, C.
    Zhang, D.
    Zeng, H.
    Wang, T.
    Gao, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1113 - S1113
  • [46] Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Suzuki, Takeshi
    Okamura, Akihiko
    Watanabe, Masayuki
    Mine, Shinji
    Imamura, Yu
    Asari, Takao
    Osumi, Hiroki
    Nakayama, Izuma
    Ichimura, Takashi
    Ogura, Mariko
    Ooki, Akira
    Takahari, Daisuke
    Yamaguchi, Kensei
    Chin, Keisho
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (05) : 1510 - 1517
  • [47] Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Takeshi Suzuki
    Akihiko Okamura
    Masayuki Watanabe
    Shinji Mine
    Yu Imamura
    Takao Asari
    Hiroki Osumi
    Izuma Nakayama
    Takashi Ichimura
    Mariko Ogura
    Akira Ooki
    Daisuke Takahari
    Kensei Yamaguchi
    Keisho Chin
    Annals of Surgical Oncology, 2020, 27 : 1510 - 1517
  • [48] Comparison of efficacy and safety of salvage-line nivolumab monotherapy between 240 and 480 mg for advanced esophageal squamous cell carcinoma.
    Murashima, Yuko
    Yamamoto, Shun
    Hirose, Toshiharu
    Kadono, Toru
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 317 - 317
  • [49] Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma.
    Yang, Guozhen
    Su, Xiaodong
    Yang, Hong
    Luo, Guangyu
    Gao, Chan
    Zheng, Yating
    Xie, Wenzhuan
    Huang, Mengli
    Bai, Yuezong
    Wang, Zhiqiang
    Cai, Peiqiang
    He, Haoqiang
    Xiang, Jin
    Cai, Muyuan
    Zhang, Yijun
    Qu, Chunhua
    Fu, Jianhua
    Liu, Qianwen
    Hu, Yi
    Zhong, Jiudi
    Huang, Yuanheng
    Guo, Qiyu
    Zhang, Xu
    CANCER RESEARCH, 2021, 81 (13)
  • [50] Retrospective evaluation of adverse events of neoadjuvant or induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal squamous cell carcinoma
    Mitsuhiro Sugawara
    Chikatoshi Katada
    Natsuya Katada
    Kaoru Takahashi
    Katsuhiko Higuchi
    Shouko Komori
    Hiromitsu Moriya
    Hiromichi Ishiyama
    Keishi Yamashita
    Shinichi Sakuramoto
    Satoshi Tanabe
    Wasaburo Koizumi
    Kazuo Yago
    Esophagus, 2013, 10 : 65 - 69
12345